Connect with us

cannabinoids

Illinois Delta-8 Regulation Bill Stalls in House of Representatives

Published

on


An Illinois bill to legalize hemp-derived cannabinoids such as delta-8 THC has stalled in the House of Representatives after lawmakers left the state capitol without passing the legislation that would have banned sales of the popular products. 

The measure was supported by many representatives of Illinois’ regulated marijuana industry who argue that unregulated hemp products give minors unfettered access to intoxicating substances and are a risk to consumers. Hemp advocates maintain, however, that the bill will destroy the fledgling industry and the small businesses it supports.

Jennifer Weiss, the owner of Chicago-based Cubbington’s Cabinet, a manufacturer and retailer of personal and pet CBD-infused products, said the bill jeopardizes the viability of the business.

“The bill is so restrictive it would outlaw almost everything in my store,” Weiss said, according to a report from local news.

Over the weekend, the Illinois Senate voted 54-1 to approve a bill that would have limited sales of hemp products that contain THC to licensed marijuana dispensaries. Democratic Senator Kimberly Lightford, the sponsor of the bill, said the legislation was a bipartisan attempt to control unregulated sales of delta-8 THC and other intoxicating hemp cannabinoids. But on Wednesday, members of the House of Representatives adjourned for the summer without taking up Lightford’s bill.

“After months of negotiations, the Senate passed a bipartisan bill that all sides agreed upon, further ensuring our common goal to have a fair, just and safe industry,” Lightford said in a statement, the Chicago Sun-Times reported. “The bill we put forth showed the dire need to regulate the hemp industry before we lose yet another young life to these pervasive products. It’s unfortunate the House could not meet the urgency.”

Competing Bill Also Stalled

Democratic state Rep. La Shawn Ford agrees that sales of delta-8 and other intoxicating cannabinoids need to be regulated but says that the bill passed by the Senate is not an appropriate solution. Ford sponsored a competing bill favored by the hemp industry, but the House of Representatives failed to advance the legislation.

“We don’t want pop-up smoke shops opening on every corner,” said Democratic state Representative La Shawn Ford. “We need to make sure we have some licenses and limit how many we have, so we don’t turn Chicago into ‘Delta and Marijuana City.’”

Ford’s bill would allow existing hemp companies to continue doing business by obtaining a $500 license and completing required product testing. The bill would also levy a 10% tax on hemp businesses and restrict sales of hemp products to adults aged 21 and older.

“It’s not like we can get rid of it. You can’t ban something that’s grown like this,” Ford said. “Let’s not try to have an industry that directly competes with cannabis. Put this industry in its own lane, just like beer is in its own lane and rum and spirits are in their own lane.”

Tiffany Chappell Ingram, executive director of the Cannabis Business Association of Illinois that backed Lightford’s bill, said that members of the group “are disappointed the House failed to pass needed reforms to our state’s cannabis laws and will continue to allow synthetic hemp products that are sickening children and adults to be sold with no oversight.”

“Despite overwhelming bipartisan support for these measures in the Senate, there is clearly more work to do to educate legislators about these important matters,” Chappell said in a statement.

Adam Terry, CEO of cannabis-infused beverages manufacturer Cantrip, encouraged lawmakers to continue working to develop a plan to regulate hemp-derived cannabinoids.

“The Illinois legislature is trying to do what we all want – find a path to regulating the consumable hemp products market,” Terry wrote in an email to High Times. “But in the session, it didn’t get to a workable solution.”

“All good faith hemp operators are interested in affirmative regulation that lays out clear and workable guidelines,” he continued. “Any hemp operator simply clamoring to exist in a perpetually unregulated state of affairs is not serious about long-term business health or public safety.”



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Incannex Healthcare lands $60 million financing deal

Published

on


The firm last month received FDA approval to proceed with a Phase 2 trial for its psilocybin-assisted psychotherapy program.

Incannex Healthcare Inc. (Nasdaq: IXHL) announced Tuesday it has secured a financing agreement with Arena Investors, LP for up to $60 million, in a bid to advance the company’s clinical-stage drug candidates.

The deal includes up to $10 million in secured convertible notes and a $50 million equity line of credit. The Australia-based Incannex plans to use the funds to support ongoing clinical trials and general corporate purposes, it said.

“We are pleased to be partnering with Arena and ABS on this strategic financing, which strengthens Incannex’s ability to advance our lead programs through key late-stage clinical milestones,” Joel Latham, Incannex’s President and CEO, said in a statement.

The financing arrangement provides for an initial funding tranche of $3.33 million upon closing, with the option for two additional tranches totaling up to $6.67 million. All tranches include a 10% original issue discount.

Additionally, the $50 million ELOC agreement with Arena affiliate Arena Business Solutions (ABS) gives Incannex the flexibility to issue and sell shares of common stock over a 36-month period, the company said.

Incannex is currently conducting several clinical trials for psychedelic and cannabinoid-based drugs, including:

  • Phase 2/3 study of IHL-42X for obstructive sleep apnea
  • Phase 2 trial of PsiGAD for generalized anxiety disorder
  • Phase 2 study of IHL-675A for rheumatoid arthritis

The company said it recently completed dosing in a 115-participant bioavailability/bioequivalence trial for IHL-42X. It also received approval from the Food and Drug Administration to proceed with a 94-patient Phase 2 clinical trial for its psilocybin-assisted psychotherapy program, PsiGAD, using Incannex’s psilocybin compound known as PSX-001.

Arena Investors, LP, with $3.5 billion in invested and committed assets under management as of June 30, according to the news release, specializes in providing capital to complex industries, including healthcare.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
Business2 days ago

Massachusetts regulators order single-lab testing to combat cannabis lab shopping

Business2 days ago

Cansortium completes merger with RIV Capital, plans to scale up in New York

Business2 days ago

The Daily Hit: December 19, 2024

Business2 days ago

Legal cannabis brands find their footing in New York

Business2 days ago

Oregon Cannabis: State of the State (2024) – Cannabis Business Executive

Business2 days ago

Marijuana activist leaders optimistic for progress in 2025

Business3 days ago

cbdMD posts lower annual sales, mixed fourth quarter

Business3 days ago

Vireo nabs $75M through 120M new shares, goes on acquisition spree

Business3 days ago

The Daily Hit: December 18, 2024

Beena Goldenberg3 days ago

Organigram eyes global cannabis growth after Motif deal

Business3 days ago

Farm Bill extension leaves hemp industry intact for now, including intoxicating products

cannabis cafes3 days ago

Cannabis predictions for 2025: Low prices, high taxes, and hash

Business3 days ago

Bat Feces Used to Fertilize Cannabis Is Linked to 2 Deaths – Cannabis Business Executive

Business3 days ago

Cannabis Potency Testing Needs to Be Done the Right Way for Consumer Protection – Cannabis Business Executive

Business3 days ago

Charlie Fox opens largest northeast dispensary in Times Square

Business3 days ago

Massachusetts regulators advance social cannabis consumption rules

Business3 days ago

MediPharm Labs sells Ontario facility for C$5.5M as part of streamlining plan

Strains & products3 days ago

2024’s weed award winners and where to buy them

Alabama3 days ago

The Daily Hit: December 17, 2024

Business4 days ago

Ohio marijuana market continues maturing with new rules

Business4 days ago

Weedmaps co-founders bid to take company private

Business4 days ago

Organigram tops estimates, expands international reach ahead of major deal

Business4 days ago

Michigan’s cannabis prices continue to free fall, spelling trouble for industry

Business4 days ago

Kentucky governor defends out-of-state dominance during medical cannabis licensing lottery

Mississippi Cannabis News8 months ago

Mississippi city official pleads guilty to selling fake CBD products

Bay Smokes6 months ago

Free delta-9 gummies from Bay Smokes

California8 months ago

May 2024 Leafly HighLight: Pink Runtz strain

Breaking News7 months ago

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

Mississippi Cannabis News7 months ago

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows

best list5 months ago

5 best CBD creams of 2024 by Leafly

cbd7 months ago

New Study Analyzes the Effects of THCV, CBD on Weight Loss

California Cannabis Updates7 months ago

Alert: Department of Cannabis Control updates data dashboards with full data for 2023 

Breaking News7 months ago

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Asia Pacific & Australia7 months ago

Thailand: Pro-cannabis advocates rally ahead of the government’s plan to recriminalize the plant

Mississippi Cannabis News7 months ago

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

California Cannabis Updates8 months ago

Press Release: May 9, STIIIZY and Healing Urban Barrios hosted an Expungement Clinic & Second Chance Resource Fair

Dispensaries6 months ago

Ohio legal cannabis buyer’s guide to 2024

One-Hit Wonders7 months ago

Marijuana Rescheduling: Why Opponents Have No Idea What They Are Talking About

DEA7 months ago

President Biden Announces Federal Government Will Reschedule Cannabis in ‘Monumental’ Announcement

adult-use cannabis7 months ago

Monitoring Weed’s Business Landscape

Mississippi Cannabis News6 months ago

Medical Cannabis changes to take effect July 1

adult-use cannabis7 months ago

Majority of Texans Now Support Legalizing Pot for Adult Use

Pot Luck7 months ago

Benefits of Kratom: Uses, Effects And More 

Business8 months ago

Planet 13 reports $6M loss in first quarter, preps for Florida expansion

Asia Pacific & Australia8 months ago

Australia: Legalise Cannabis MP Sophia Moermond quits party over offshore wind farm opposition

Mississippi Cannabis News7 months ago

Cannabis lab files appeal with Mississippi State Department of Health

adult-use cannabis7 months ago

DeSantis Likely To Veto Hemp Bill that Would Limit THC, Sources Say

California8 months ago

Senator Cory Booker Visits Sacramento Cannabis Giant Amid Decriminalization Push

Trending